| Schedule of Listing expense |
The excess of fair value of TNL Mediagene ordinary shares issued over the fair value of Blue Ocean’s identifiable net assets acquired represents compensation for the service of a stock exchange listing for its shares and was expensed as incurred, the summary of which is as follows:
|
|
|
Listing expense
|
| |
|
Shares
|
|
Amount
|
|
Fair value of TNL Mediagene equity consideration issued:
|
|
|
|
|
|
|
|
Public shareholders
|
|
63,903 |
|
$
|
685,040 |
|
|
Sponsor shareholders (Note 1)
|
|
2,726,418 |
|
|
29,227,201 |
|
|
Total value of TNL Mediagene shares issued to Blue Ocean shareholders (Note 2)
|
|
|
|
|
29,912,241 |
|
|
Net assets of Blue Ocean as of December 5, 2024
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
|
|
2,653 |
|
|
Financial assets at fair value through profit or loss
|
|
|
|
|
741,839 |
|
|
Other payables
|
|
|
|
|
(5,396,683 |
)
|
|
Promissory notes
|
|
|
|
|
(2,562,102 |
)
|
|
Financial liabilities at fair value through profit or loss
|
|
|
|
|
(610,028 |
)
|
|
Other liabilities
|
|
|
|
|
(424,184 |
)
|
|
Total net assets of Blue Ocean as of December 5, 2024
|
|
|
|
|
(8,248,505 |
)
|
|
Excess of fair value of TNL Mediagene consideration issued over Blue Ocean net assets acquired
|
|
|
|
$
|
38,160,746 |
|
|